@odlerb

MD PhD | Nephrologist with interest in kidney autoimmunity at the @MedUniGraz | ERA YNP Board Member | views my own 🇪🇺

 Graz, Österreich
Joined December 2018
  • Tweets384
  • Following259
  • Followers406
31Media
Just published in @Kidney_Int - The impact of PLEX and GC on early kidney function changes in AAV. (kidney-international.org/art…) This analysis provides another important piece of the “PLEX puzzle”. Many thanks to my co-authors, the PIs and especially to @AKronbichler and David Jayne.

The effects of plasma exchange and glucocorticoids on early kidney function among patients with...

Therapeutic plasma exchange (PLEX) is an adjunctive treatment for patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis and kidney involvement. Little is known about the...

kidney-international.org
4
5
31
1,629
Balazs Odler retweeted
YNP of ERA
@ynptweetsSep 15
1/How should we recognize and manage fibromuscular dysplasia (FMD)? Check out these 10 practical tips covering diagnosis, imaging, treatment, and follow-up of patients with FMD. 📝 YNP author: Julie Piotte 🧵 by @AgavriloaeiB
@CKJsocial @ERAkidney
1
6
1
9
610
Balazs Odler retweeted
YNP of ERA
@ynptweetsAug 17
1/ What is the quality of life in patients with ADPKD? 👉🏻Check out this systematic review that explores the quality of life in patients with ADPKD. 📝 YNP author: Matt Gittus 🧵 by @AgavriloaeiB
@CKJsocial @ERAkidney
1
7
1
8
464
Balazs Odler retweeted
YNP of ERA
@ynptweetsJul 27
Can weight-loss therapies improve cardiorenal outcomes in people with CKD and type 2 diabetes? @tomwilks444 is the YNP author 👀 Check out our latest snapshot prepared by @jt_nephrology @ERAkidney @NDTsocial
8
13
718
Balazs Odler retweeted
YNP of ERA
@ynptweetsMar 18
👉🏻 Check out this month snapshot summary about CAKUT disease in adult patients doi.org/10.1093/ndt/gfaf172 ✍️Charlotte Hammett is the YNP author Post prepared by @jt_nephrology @NDTsocial @ERAkidney
15
15
1,222
Balazs Odler retweeted
YNP of ERA
@ynptweetsMar 5
Apply to be a board member of the YNP! 👇🏻
ERA - European Renal Association
@ERAkidneyMar 5
💥 2026 ERA Open Calls: join the official ERA Bodies! 📅Apply by March 26, 2026 for: 🤝Working Groups: CKD-MBD, Diabesity, ERAKI, ERN, EuDial, G&K, IWG 📚Committees: ETHICS, Kidney Relief in Disasters, Strong Kidneys, Sustainable Nephrology, Young Nephrologists’ Platform, Women of ERA 🎙️Podcast Team Apply now 👉 bit.ly/4hl2N1n
6
5
1,306
Balazs Odler retweeted
YNP of ERA
@ynptweetsFeb 19
🪨 Kidney stones: Time to nephrologists to reclaim the field? 👀Check out our latest post with 10 tips on work-up and management of CKD patients with nephrolithiasis. Gerlineke Hawkins-van der Cingel is the YNP author  🧵by @jt_nephrology @CKJsocial @ERAkidney
1
17
40
2,748
I am glad to work together with leading experts in the field of rare kidney diseases! Together these diseases are common! Thank you @GlomCon
glomcon
@GlomCon23 Dec 2025
🚨 We are pleased to announce the upcoming launch of GlomCon’s Rare Kidney Disease Journal, a new peer-reviewed journal developed in partnership with @SpringerNature. This journal will serve as a global platform dedicated to advancing research, clinical practice, and innovation in rare and complex kidney diseases.
12
11
52
3,533
Balazs Odler retweeted
YNP of ERA
@ynptweets15 Dec 2025
🙌🏻 Check out this month snapshot summary about pharmacologial differences between man and woman with CKD doi.org/10.1093/ndt/gfaf125 @SoleneLaville is the YNP author Post prepared by @jt_nephrology @ERAkidney @NDTsocial
12
16
1,459
Balazs Odler retweeted
YNP of ERA
@ynptweets24 Nov 2025
Apply now! Such a great opportunity! 👇🏻
ERA - European Renal Association
@ERAkidney24 Nov 2025
🚨 YNP Mentorship Programme: The applications for Mentees are open! 🌟 Are you a young professional or a medical student, trainee or fellow? 🔍 Discover the inspiring perspectives of mentees and mentors who have experienced it before you 🗓 Deadline: January 30, 2026 Apply now 👉 bit.ly/48dubvT
5
5
513
Balazs Odler retweeted
YNP of ERA
@ynptweets17 Oct 2025
1/ 🧬 CRISPR and gene editing for kidney diseases: Where do we stand in 2025? A review on how CRISPR and other gene editing tools are redefining what’s possible in nephrology — from fixing mutations to regenerating kidney tissue. @Violadmb is the YNP author 🧵 by @jt_nephrology @CKJsocial @ERAkidney
1
10
13
1,281
ANCA-negative pauci-immune glomerulonephritis must be one of the most challenging fields in vasculitis. In this commentary in @KIReports, we discuss some open questions on this topic. kireports.org/article/S2468-…

Antineutrophil Cytoplasmic Antibody–Negative Pauci-Immune Glomerulonephritis: Still Many Unknowns

Antineutrophil cytoplasmic antibody (ANCA)-negative vasculitis must be the most challenging entity in the vasculitis field, shedding doubt on whether ANCA are truly pathogenic (O yes they are!),1...

kireports.org
16
33
1,692
We’re calling on researchers, clinicians, and educators—share your work with the global vasculitis community! Submit your abstract by 19 September 2025—don’t miss your chance to be part of this exciting event! vasculitis-melbourne2026.com… #VasculitisMelbourne2026
18
1
23
3,571
📢 Join us at the YNP & EFIM joint e-seminar: *Cardiorenal Syndrome – Perspectives from Nephrology and Internal Medicine* 📅 Wednesday, May 14, 2025, 5:00 PM (CEST) Register now 👉 bit.ly/4jXCuQA
8
1
24
2,590
Balazs Odler retweeted
YNP of ERA
@ynptweets24 Mar 2025
1/ New thread on recently published @CKJsocial paper by @luisloureiro4 using target trial emulation to assess impact of arteriovenous fistula 🩸 formation on kidney function decline 📉 Link 👉 doi.org/10.1093/ckj/sfae345 🧵by @richard_shemilt

Impact of arteriovenous fistula formation on trajectory of kidney function decline: a target trial...

ABSTRACTBackground. Prior nonrandomized studies have suggested nephroprotective effects of arteriovenous fistula (AVF) formation, but these are plausibly s

academic.oup.com
1
13
13
1,245
Recently, post-hoc analyses of the PEXIVAS trial have provided new insights into the use of PLEX in #AAV. In this viewpoint, we highlight clinical scenarios where its use may be benefical. Don’t miss „Viewpoint 1“ by Mike Walsh. academic.oup.com/rheumatolog…

Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 2: plasma exchange may be...

Abstract. The use of plasma exchange (PLEX) as adjunct therapy in the initial management of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculit

academic.oup.com
1
7
1
21
9,453
@AKronbichler, @WLASZ
140
Check out our newest paper on a practical approach to common nephrology consultations. 👇🏻 Great job @KollandMichael, @saberger_ , @alehkir ! 👌🏻 academic.oup.com/ckj/advance…

It's Friday, 3 p.m., and the phone rings ... a practical approach to common nephrology consultati...

ABSTRACT. This practical approach highlights the importance of timely recognition and management of various nephrological emergencies. The featured conditi

academic.oup.com
1
8
21
826
The effects of #plasmaexchange and #glucocorticoids on early kidney function among patients with #ANCA-associated #vasculitis in the PEXIVAS trial doi.org/10.1016/j.kint.2024.… #OpenAccess #glomerulonephritis #ESKD
35
2
81
6,706
✅ Let's see who will bring forward the best arguments 😏😇 #Lupus nephritis - standard of care (for all, will already be something)
Autoimmunity Network@autoimmunitymd7 Jan 2025
Debate 3 at #CORA2025: LN Treatment—Early Combination vs. Standard? 🔸 Ioannis Parodis (Sweden) argues for Early Combination 🔸 Laurent Arnaud (France) advocates for Standard Treatment Review the topics: bit.ly/4fGmsZ0 #Lupus #SLE #Rheumatology #Autoimmunity #Rheum
3
12
51
3,189
Lupus nephritis: redefining the treatment goals doi.org/10.1016/j.kint.2024.… #KIEditorial #OpenAccess #lupusnephritis @MayoClinicNeph @MayoClinicPath
1
81
193
11,430
Load more